Key facts
- It has raised $4.1M; the latest was Seed Round ($4.1M) in May 2025.
- Notable investors include Hunan Lushan Technology Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhongke Muan
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Muan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Muan
Manufacturer of veterinary biotechnology products aims to improve animal health and sustainable livestock support. The company's offerings feature advanced biological veterinary medicines, including vaccines, probiotics, and nutritional supplements, supported by R&D, quality-controlled production, and collaborative field deployment in Hunan and beyond, helping livestock farms and veterinary clinics prevent disease, enhance animal wellness, and boost production efficiency, enabling scalable and reliable bio-veterinary support across the agriculture sector.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Changsha, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Zhongke Muan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Muan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Muan in its N-PORT filings yet. We sweep new filings monthly.